Xiaojie Shi
Department of Cardiovascular Medicine, Xiangcheng People's Hospital, Xuchang 461799, Henan, China.
*Corresponding author: Xiaojie Shi
Abstract
Objective: To investigate the serious complications after interventional therapy of clinical cardiovascular disease. Methods: 400 patients with cardiovascular disease who received interventional therapy in our hospital from March 2020 to May 2022 were selected, among which 30 patients had serious complications after receiving interventional therapy. This study and 30 patients with complications were taken as research objects, and the specific status of treatment and complications of all patients were statistically studied. Results: The statistical analysis showed that the complication rate was 9.32% in the elective cardiac group, 7.92% in the emergency cardiac group, and 6.52% in the vascular group. The incidence of serious complications in the elective group was significantly higher than that in the other groups (P < 0.05). The clinical manifestations of serious complications after interventional therapy of cardiovascular diseases were severe arrhythmia, hematoma at puncture point, anaphylactic shock at contrast dose, etc. The incidence of these three clinical symptoms were 23.33%, 16.67%, 16.67%, respectively, and compared with other clinical symptoms, the difference was significant (P < 0.05). Conclusion: Puncture point hematoma, arrhythmia and contrast anaphylactic shock are common complications after interventional therapy of clinical cardiovascular diseases. Attention should be paid to the interventional therapy and effective countermeasures should be taken to effectively control the incidence of complications and mortality.
References
[1] Han Weiyu, Chen Yuanxing, Huang Youyang, Liu Weiwei, Zhao Yongchao, Zhao Ranzun. Histone deacetylation modulates the occurrence and development of cardiovascular diseases[J/OL]. Chinese Journal of Tissue Engineering Research.
[2] Lei Ziqin, Luan Fei, Gao Ming, Hu Jingwen, Zeng Nan. Research progress on the relationship between cell pyroptosis and cardiovascular disease and prevention and treatment of traditional Chinese medicine [J/OL]. Chinese Journal of Traditional Chinese Medicine: 1-15 [2023-02-08].
[3] Yang Ying, Zhang Zhiguo, Chen Yanjing. Clinical application and mechanism of Huangqi Guizhi Wuwu Decoction in cardiovascular diseases[J/OL]. Chinese Journal of Basic Medicine of Traditional Chinese Medicine: 1-9 [2023-02-08].
[4] Cai Ming, Wang Liyan, Yang Ruoyu, Liang Leichao, Yang Yuanyuan, Jia Shihao, Chen Ruiyi, Ren Yu, Liu Qianle, Hu Jingyun. A randomized controlled trial of short-term high-intensity interval training to reduce the accumulation of advanced glycation end products and cardiovascular disease risk in female college students with latent obesity[J/OL]. Chinese General Practice.
[5] Liao Xiaobo, Xiao Peng. Analysis of risk prediction model for depression in elderly patients with cardiovascular disease[J]. Public Health and Preventive Medicine, 2022, 33(06): 144-147.
[6] Yu Rui, Wang Xinlu, Wang Jianru, Zhao Qifei, Peng Guangcao, Li Bin, Li Xingyuan, Zhu Mingjun. Construction and thinking of the prevention and control model of cardiovascular disease combining traditional Chinese and western medicine[J]. Modern Distance Education of Traditional Chinese Medicine, 2022, 20(21): 196-199.
How to cite this paper
Discussion on Severe Complications After Interventional Treatment of Cardiovascular Diseases
How to cite this paper: Xiaojie Shi. (2024). Discussion on Severe Complications After Interventional Treatment of Cardiovascular Diseases. Cardiovascular Research and Therapy, 1(1), 5-8.
DOI: http://dx.doi.org/10.26855/crt.2024.12.002